Previous 10 | Next 10 |
MORRISVILLE, N.C., April 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial results on Thursday, April 29, 2021, prior to its earnings call at 8:00 a.m. ET. ...
MORRISVILLE, N.C. and LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Science 37, the industry’s only Decentralized Clinical Trial Operating System™, today...
Healthcare supply chain and pharma services companies weathered the COVID-19 volatility fairly well, and adapted to new realities along the way, Baird notes with the Q4 results in the rear-view mirror. The contract research organizations posted constant-dollar organic revenue growth of 10.2% ...
MORRISVILLE, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health ® agencies designed to deliver insights-driven integrated communications spanning advertising, public relations, patient advocacy, medical communications, mana...
Syneos Health ([[SYNH]] -4.1%) announces that it has commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners and Advent International of an aggregate of 7M shares.The selling stockholders intend to grant the underwriter a 30-day option to purchase up to 1M additio...
MORRISVILLE, N.C. and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Protocol First, Inc., a software solutions provider focused on accelerating clinical research, today announ...
MORRISVILLE, N.C., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health ® agencies designed to deliver insights-driven integrated communications spanning advertising, public relations, patient advocacy, medical communications, manag...
Syneos Health, Inc. (SYNH) Q4 2020 Earnings Conference Call February 18, 2021, 08:00 AM ET Company Participants Ronnie Speight - SVP, IR Alistair Macdonald - CEO Jason Meggs - CFO Paul Colvin - President, Clinical Solutions Michelle Keefe - President, Commercial Solutions Conference Call Part...
Image source: The Motley Fool. Syneos Health, Inc. (NASDAQ: SYNH) Q4 2020 Earnings Call Feb 18, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Syneos Health, Inc. (SYNH) Q4 2020 Earnings Call Transcript
The following slide deck was published by Syneos Health, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Syneos Health, Inc. 2020 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...